Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 16, 2019 02:45 ET | Source: Miragen Therapeutics, Inc.

miRagen Announces New Clinical Data Showing MRG-110 Positively Impacted Tissue Repair and New Blood Vessel Growth

Data included in an oral presentation at the 15th annual meeting of the Oligonucleotide Therapeutics Society Data supports advancing MRG-110 into additional clinical studies BOULDER, Colo., Oct. ...
October 16, 2019 02:00 ET | Source: Huazhu Group Limited

Huazhu Group Limited Announces Preliminary Results for Hotel Operations in the Third Quarter of 2019

Net revenue for 2019 Q3 is expected to increase by 10%-11% year-over-year, in line with guidance.Our unopened hotel pipeline further accelerated to an historical high of 1,736 hotels as of September...
October 16, 2019 01:00 ET | Source: ASML Netherlands BV

ASML reports EUR 3.0 billion sales at 43.7% gross margin in Q3

ASML reports EUR 3.0 billion sales at 43.7% gross margin in Q323 EUV orders reiterate customers' manufacturing plans in Logic and Memory VELDHOVEN, the Netherlands, October 16, 2019 - today...
October 16, 2019 01:00 ET | Source: Wisekey International Holding SA

WISeKey joins the SAP® PartnerEdge® Program

WISeKey joins the SAP® PartnerEdge® Program Geneva, Switzerland – October 16, 2019 - WISeKey International Holding Ltd (WIHN.SIX), a Swiss based cyber security company, today announced that it has...
October 16, 2019 00:12 ET | Source: Bionano Genomics

Top Researchers to Present Discoveries Made Possible by Bionano’s Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual Meeting

SAN DIEGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that disease researchers using Bionano’s Saphyr system for whole genome imaging will present their...
October 15, 2019 23:17 ET | Source: ProQR Therapeutics N.V.

ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares

LEIDEN, The Netherlands and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical company dedicated to changing lives through the...
October 15, 2019 23:01 ET | Source: Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering

BOSTON, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment...
October 15, 2019 22:24 ET | Source: Principia Biopharma Inc.

Principia Announces Pricing of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing novel therapies for immune...
October 15, 2019 18:15 ET | Source: Editas Medicine, Inc.; Asklepios BioPharmaceutical, Inc.

Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases

CAMBRIDGE, Mass. and RESEARCH TRIANGLE PARK, N.C., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, and Asklepios BioPharmaceutical, Inc....
October 15, 2019 17:41 ET | Source: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Reaffirms Full Year 2019 Revenue Guidance and Will Announce Third Quarter 2019 Financial Results and Recent Business Highlights on November 6, 2019

WARREN, N.J., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to...